Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 295-322-3 | CAS number: 91995-60-7
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Based on the considerations described in the document "Read-across substantiation C5-6 branched alkylmethyl-ethers” (incl. the supporting references Tuppurainen et al., 2007 and Niska et al., 2008), it can be concluded that the available information of TAME can be used to predict the sensitisation properties of the substance ‘C5-6 branched alkylmethyl-ethers’ with sufficient certainty.
TAME was considered not sensitising in a guinea pig Bühler test performed according to USEPA Toxic Substance Control Act specification and under GLP (Pharmaco LSR, 1995). The incidence index in the positive control animals was 100%. None of the animals induced and challenged with TAME showed a dermal response, the incidence index and severity score being zero.
Migrated from Short description of key information:
The substance is not expected to have skin sensitising properties.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
- Migrated from Short description of key information:
No information available. However, respiratory tract sensitisation is not expected as no positive human data is available suggesting that the substance causes respiratory tract sensitisation. In addition, there is no evidence of respiratory tract effects reported in repeated exposure inhalation studies in animals.
Justification for classification or non-classification
Based on the available data, TAME is considered to be not sensitising. In accordance with Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008, classification of ATME is not necessary for sensitisation.
Based on the proposed read-across approach, this non-classification does also apply for C5-6 branched alkylmethyl-ethers.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
